CD8A and myeloid sarcoma: We have shown that the decreased CD8+ T cell response to LCL in MS is not due to decreased HLA class I expression on the LCL and that LCL from patients with MS can be killed normally by HLA matched EBV specific cytotoxic CD8+ T cell clones from healthy subjects.